Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 19, Issue 12, pp. 2490-2501
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 10, 2019
- Revision received January 6, 2020
- Accepted September 24, 2020
- Published first October 6, 2020.
Article Versions
- Previous version (October 6, 2020 - 08:48).
- Previous version (November 16, 2020 - 07:47).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Yifan Kong1,2,
- Yanquan Zhang1,
- Fengyi Mao1,2,
- Zhuangzhuang Zhang1,
- Zhiguo Li1,
- Ruixin Wang1,
- Jinghui Liu1, and
- Xiaoqi Liu1,3,*
- 1Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
- 2Department of Animal Sciences, Purdue University, West Lafayette, Indiana.
- 3Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
- ↵*Corresponding Author:
Xiaoqi Liu, University of Kentucky, Lexington, KY 40536. Phone: 859-257-3760; Fax: 859-323-1059; E-mail: Xiaoqi.Liu{at}uky.edu
December 2020
Volume 19, Issue 12
Volume 19, Issue 12
Inhibition of EZH2 Enhances the Antitumor Efficacy of Metformin in Prostate Cancer
Jump to section
Advertisement